Detalles de la búsqueda
1.
Bexotegrast in Patients with Idiopathic Pulmonary Fibrosis: The INTEGRIS-IPF Study.
Am J Respir Crit Care Med
; 2024 Jun 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-38843105
2.
Revefenacin Absorption, Metabolism, and Excretion in Healthy Subjects and Pharmacological Activity of Its Major Metabolite.
Drug Metab Dispos
; 48(12): 1312-1320, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-32978223
3.
Efficacy of revefenacin, a long-acting muscarinic antagonist for nebulized therapy, in patients with markers of more severe COPD: a post hoc subgroup analysis.
BMC Pulm Med
; 20(1): 134, 2020 May 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-32393215
4.
Maintained therapeutic effect of revefenacin over 52 weeks in moderate to very severe Chronic Obstructive Pulmonary Disease (COPD).
Respir Res
; 20(1): 241, 2019 Oct 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-31666076
5.
Cardiovascular safety of revefenacin, a once-daily, lung-selective, long-acting muscarinic antagonist for nebulized therapy of chronic obstructive pulmonary disease: Evaluation in phase 3 clinical trials.
Pulm Pharmacol Ther
; 57: 101808, 2019 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-31152911
6.
A 28-day, randomized, double-blind, placebo-controlled, parallel group study of nebulized revefenacin in patients with chronic obstructive pulmonary disease.
Respir Res
; 18(1): 182, 2017 11 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-29096627
7.
A randomized, double-blind, placebo-controlled, phase 2b study of the efficacy and safety of velusetrag in subjects with diabetic or idiopathic gastroparesis.
Neurogastroenterol Motil
; 35(4): e14523, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36624727
8.
Blinded, Double-Dummy, Parallel-Group, Phase 2a Randomized Clinical Trial to Evaluate the Efficacy and Safety of a Highly Selective 5-Hydroxytryptamine Type 4 Receptor Agonist in Critically Ill Patients With Enteral Feeding Intolerance.
JPEN J Parenter Enteral Nutr
; 45(1): 115-124, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31990087
9.
Velusetrag accelerates gastric emptying in subjects with gastroparesis: a multicentre, double-blind, randomised, placebo-controlled, phase 2 study.
Aliment Pharmacol Ther
; 53(10): 1090-1097, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33811761
10.
Tildacerfont in Adults With Classic Congenital Adrenal Hyperplasia: Results from Two Phase 2 Studies.
J Clin Endocrinol Metab
; 106(11): e4666-e4679, 2021 10 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-34146101
11.
Safety and Efficacy of Revefenacin and Formoterol in Sequence and Combination via a Standard Jet Nebulizer in Patients with Chronic Obstructive Pulmonary Disease: A Phase 3b, Randomized, 42-Day Study.
Chronic Obstr Pulm Dis
; 7(2): 99-106, 2020 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-32324981
12.
Efficacy and safety of revefenacin for nebulization in patients with chronic obstructive pulmonary disease taking concomitant ICS/LABA or LABA: subgroup analysis from phase III trials.
Ther Adv Respir Dis
; 14: 1753466620905278, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32106777
13.
Peak Inspiratory Flows: Defining Repeatability Limits and a Predictive Equation for Different Inhalers.
Chest
; 158(4): 1413-1419, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32343967
14.
Revefenacin, a Long-Acting Muscarinic Antagonist, Does Not Prolong QT Interval in Healthy Subjects: Results of a Placebo- and Positive-Controlled Thorough QT Study.
Clin Pharmacol Drug Dev
; 9(1): 130-139, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31468714
15.
Pharmacokinetics and safety of revefenacin in subjects with impaired renal or hepatic function.
Int J Chron Obstruct Pulmon Dis
; 14: 2305-2318, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31632000
16.
Clinical Experience with Telavancin: Real-World Results from the Telavancin Observational Use Registry (TOUR™).
Drugs Real World Outcomes
; 6(4): 183-191, 2019 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-31696440
17.
Nebulized Versus Dry Powder Long-Acting Muscarinic Antagonist Bronchodilators in Patients With COPD and Suboptimal Peak Inspiratory Flow Rate.
Chronic Obstr Pulm Dis
; 6(4)2019 Oct 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-31647854
18.
Data on the safety and tolerability of revefenacin, in patients with moderate to very severe chronic obstructive pulmonary disease.
Data Brief
; 26: 104277, 2019 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-31534988
19.
Telavancin in Hospital-Acquired and Ventilator-Associated Pneumonia (HAP/VAP) Caused by Staphylococcus aureus: Post Hoc Analysis of 2 Randomized, Controlled Trials.
Infect Dis Ther
; 8(3): 445-452, 2019 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-31372837
20.
Improvements in Lung Function with Nebulized Revefenacin in the Treatment of Patients with Moderate to Very Severe COPD: Results from Two Replicate Phase III Clinical Trials.
Chronic Obstr Pulm Dis
; 6(2): 154-165, 2019 Apr 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-30974049